StockData
Mangoceuticals, Inc. logo

Mangoceuticals, Inc. (MGRX) stock

MGRXNasdaqServices-Misc Health & Allied Services, NECFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 7/30
$0.15−0.01 (-8.44%)

Close on Nov 18, 2026Market cap $3.16MP/E –Yield –

Mangoceuticals revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Mangoceuticals's revenue for the twelve months ending Jun 30, 2026 was $315.23K, down 38.9% year over year. For fiscal 2025 it was $456.02K, down 26.0% from the year before.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$456.02K-26.0%
FY2024Dec 31, 2024$615.87K-15.8%
FY2023Dec 31, 2023$731.49K+8083.2%
FY2022Dec 31, 2022$8.94K–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$68.76K-59.1%
Q1 FY2026Mar 31, 2026$67.86K-37.9%
Q4 FY2025Dec 31, 2025$94.36K-10.3%
Q3 FY2025Sep 30, 2025$84.25K-36.8%
Q2 FY2025Jun 30, 2025$168.11K+3.0%
Q1 FY2025Mar 31, 2025$109.31K-48.9%
Q4 FY2024Dec 31, 2024$105.25K-56.9%
Q3 FY2024Sep 30, 2024$133.37K-45.6%
Q2 FY2024Jun 30, 2024$163.16K+15.5%
Q1 FY2024Mar 31, 2024$214.10K+112.6%
Q4 FY2023Dec 31, 2023$244.37K–
Q3 FY2023Sep 30, 2023$245.16K–
Q2 FY2023Jun 30, 2023$141.24K–
Q1 FY2023Mar 31, 2023$100.72K–

More Mangoceuticals figures

See a number that looks wrong?